109 related articles for article (PubMed ID: 12018779)
1. A random-effects mixture model for classifying treatment response in longitudinal clinical trials.
Xu W; Hedeker D
J Biopharm Stat; 2001 Nov; 11(4):253-73. PubMed ID: 12018779
[TBL] [Abstract][Full Text] [Related]
2. A mixed-effects regression model for longitudinal multivariate ordinal data.
Liu LC; Hedeker D
Biometrics; 2006 Mar; 62(1):261-8. PubMed ID: 16542254
[TBL] [Abstract][Full Text] [Related]
3. Applications of a mixture survival model with covariates to the analysis of a depression prevention trial.
Greenhouse JB; Silliman NP
Stat Med; 1996 Oct; 15(19):2077-94. PubMed ID: 8896141
[TBL] [Abstract][Full Text] [Related]
4. Using antipsychotic agents in older patients.
Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
[TBL] [Abstract][Full Text] [Related]
5. A mixed-effects regression model for three-level ordinal response data.
Raman R; Hedeker D
Stat Med; 2005 Nov; 24(21):3331-45. PubMed ID: 16206246
[TBL] [Abstract][Full Text] [Related]
6. Using trajectories from a bivariate growth curve as predictors in a Cox regression model.
Dang Q; Mazumdar S; Anderson SJ; Houck PR; Reynolds CF
Stat Med; 2007 Feb; 26(4):800-11. PubMed ID: 16612837
[TBL] [Abstract][Full Text] [Related]
7. An autoregressive linear mixed effects model for the analysis of longitudinal data which include dropouts and show profiles approaching asymptotes.
Funatogawa T; Funatogawa I; Takeuchi M
Stat Med; 2008 Dec; 27(30):6351-66. PubMed ID: 18767204
[TBL] [Abstract][Full Text] [Related]
8. A latent-class mixture model for incomplete longitudinal Gaussian data.
Beunckens C; Molenberghs G; Verbeke G; Mallinckrodt C
Biometrics; 2008 Mar; 64(1):96-105. PubMed ID: 17608789
[TBL] [Abstract][Full Text] [Related]
9. Moderators of placebo response to antipsychotic treatment in patients with schizophrenia: a meta-regression.
Welge JA; Keck PE
Psychopharmacology (Berl); 2003 Feb; 166(1):1-10. PubMed ID: 12494247
[TBL] [Abstract][Full Text] [Related]
10. Estimating treatment efficacy over time: a logistic regression model for binary longitudinal outcomes.
Choi L; Dominici F; Zeger SL; Ouyang P
Stat Med; 2005 Sep; 24(18):2789-805. PubMed ID: 16134133
[TBL] [Abstract][Full Text] [Related]
11. The expert consensus guideline series. Optimizing pharmacologic treatment of psychotic disorders. Introduction: methods, commentary, and summary.
Kane JM; Leucht S; Carpenter D; Docherty JP;
J Clin Psychiatry; 2003; 64 Suppl 12():5-19. PubMed ID: 14640142
[TBL] [Abstract][Full Text] [Related]
12. Semi-parametric modelling of the distribution of the baseline risk in meta-analysis.
Ghidey W; Lesaffre E; Stijnen T
Stat Med; 2007 Dec; 26(30):5434-44. PubMed ID: 17893888
[TBL] [Abstract][Full Text] [Related]
13. Control group bias in randomized atypical antipsychotic medication trials for schizophrenia.
Woods SW; Gueorguieva RV; Baker CB; Makuch RW
Arch Gen Psychiatry; 2005 Sep; 62(9):961-70. PubMed ID: 16143728
[TBL] [Abstract][Full Text] [Related]
14. Joint models for multivariate longitudinal and multivariate survival data.
Chi YY; Ibrahim JG
Biometrics; 2006 Jun; 62(2):432-45. PubMed ID: 16918907
[TBL] [Abstract][Full Text] [Related]
15. Analysis of longitudinal count data with serial correlation.
Xu S; Jones RH; Grunwald GK
Biom J; 2007 Jun; 49(3):416-28. PubMed ID: 17623346
[TBL] [Abstract][Full Text] [Related]
16. Robust linear mixed models using the skew t distribution with application to schizophrenia data.
Ho HJ; Lin TI
Biom J; 2010 Aug; 52(4):449-69. PubMed ID: 20680971
[TBL] [Abstract][Full Text] [Related]
17. Semiparametric models for missing covariate and response data in regression models.
Chen Q; Ibrahim JG
Biometrics; 2006 Mar; 62(1):177-84. PubMed ID: 16542244
[TBL] [Abstract][Full Text] [Related]
18. Meta-analysis of individual patient data versus aggregate data from longitudinal clinical trials.
Jones AP; Riley RD; Williamson PR; Whitehead A
Clin Trials; 2009 Feb; 6(1):16-27. PubMed ID: 19254930
[TBL] [Abstract][Full Text] [Related]
19. Analyzing incomplete longitudinal clinical trial data.
Molenberghs G; Thijs H; Jansen I; Beunckens C; Kenward MG; Mallinckrodt C; Carroll RJ
Biostatistics; 2004 Jul; 5(3):445-64. PubMed ID: 15208205
[TBL] [Abstract][Full Text] [Related]
20. Discrete state analysis for interpretation of data from clinical trials.
Sugar CA; James GM; Lenert LA; Rosenheck RA
Med Care; 2004 Feb; 42(2):183-96. PubMed ID: 14734956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
